Please enter a valid ZIP code

The safety of NovoSeven® RT (Coagulation
Factor VIIa [Recombinant]) is well studied

Tolerability Tolerability
Able to put up with or endure.
refers to the way your body tolerates Tolerate
The ability to endure doses of a medicine.
a medicine or treatment.

NovoSeven® RT is considered safe because it works only where it is needed—at the site of injury. So there is a low incidence of thrombosisThrombosis
An event that takes place when veins or arteries become blocked by platelets that are working to "plug" an injury, preventing blood from flowing normally through the body, and possibly causing a stroke.
, also known as blood clots, forming in other parts of your body. The most common serious adverse reactions in clinical trials are thrombotic events. The risk of thrombotic adverse events is less than 1%.*

Allergic reactions, including serious whole body allergic reactions, have been seen in people with inhibitors taking NovoSeven® RT. Some signs may include:

  • Shortness of breath
  • Rash
  • Itching
  • Redness of the skin
  • Fainting/dizziness

*In patients with hemophilia A or B with inhibitors.

Indications and Usage

NovoSeven® RT (Coagulation Factor VIIa [Recombinant]) is used for:

Important Safety Information

WARNING: BLOOD CLOTS

  • Serious blood clots that form in veins and arteries with the use of NovoSeven® RT have been reported.
  • Your healthcare provider should discuss the risks and explain the signs and symptoms of blood clots to you. Some signs of a blood clot may include pain, swelling, warmth, redness, or a lump in your legs or arms, chest pain, shortness of breath, or sudden severe headache and/or loss of consciousness or function.
  • Your healthcare provider should monitor you for blood clots during treatment with NovoSeven® RT.

Warnings and Precautions

Side Effects

Use with Other Drugs

Please click here for NovoSeven® RT Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch,
or call 1-800-FDA-1088.

NovoSeven® RT is a prescription medicine. Novo Nordisk provides patient assistance for those who qualify. Please call 1-877-NOVO-777 (1-877-668-6777) to learn more about Novo Nordisk assistance programs.